Annual report 2022
Letter to the Shareholders
medmix at a glance
Our company
Our key figures
Focus
Strategy
Business review
Financial review
Healthcare review
Consumer & Industrial review
Sustainability
Sustainability review
Corporate governance
Corporate structure and shareholders
Capital structure
Board of Directors
Executive Committee
Shareholder participation rights
Takeover and defense measures
Auditors
Risk management
Information policy
Compensation report
Overview of the financial year 2022
Compensation governance
Compensation architecture for the Executive Committee
Compensation of the Executive Committee for 2022
Compensation architecture for the Board of Directors
Compensation of the Board of Directors for 2022
Shareholdings
Auditor’s report
Consolidated financial statements
Consolidated income statement
Consolidated statement of comprehensive income
Consolidated balance sheet
Consolidated statement of changes in equity
Consolidated statement of cash flows
Notes to the consolidated financial statements
Auditor’s report
Alternative performance measures (APM)
Financial statements of medmix Ltd
Balance sheet of medmix Ltd
Income statement of medmix Ltd
Statement of changes in equity of medmix Ltd
Notes to the financial statements of medmix Ltd
Proposal of the Board of Directors for the appropriation of the available profit
Auditor’s report
Search
search-button